- Home
- App Analytics
- Arthrex Rep
Arthrex Rep app analytics for December 23
Arthrex Rep
- Arthrex, Inc.
- Apple App Store
- Free
- Medical
The Arthrex Rep App is a sales enablement tool developed for Arthrex global agency sales representatives.
About Arthrex:
Arthrex is a global leader in multispecialty minimally invasive surgical technology, scientific research, manufacturing and medical education. Arthrex pioneered the field of arthroscopy and sports medicine and develops more than 1,000 new products and related procedures annually to advance minimally invasive orthopedic surgery, trauma, spine, cardiothoracic, orthobiologics and arthroplasty innovation worldwide. Arthrex also specializes in the latest 4K multispecialty surgical visualization and OR integration technology solutions.
Arthrex continues to experience unprecedented growth and demand for its products throughout the world; however, we remain a privately held company with a family business culture committed to delivering uncompromising quality to the health care professionals (HCPs) who use our products, and ultimately, the millions of patients whose lives we impact.
We invite you to learn more about Arthrex and the positive contributions we are making to medicine and the communities we serve.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us
Arthrex Rep Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for Arthrex Rep
Rank
No Data Available
Arthrex Rep Ranking by Country
Counties in which Arthrex Rep has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Arthrex Global University
Intellum, Inc.
ArthrexVIP
ARTHREX CALIFORNIA TECHNOLOGY INC.
Synergy Surgeon2
ARTHREX CALIFORNIA TECHNOLOGY INC.
Torq Mobile
Torq Interface, Inc.
Arthrex Rep VS.
December 23, 2024